Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $55.8M
Liabilities Breakdown FY2022
Total Liabilities: $66.4M
Asset Breakdown
Total Assets: $55.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.1M | 30.7% |
| Accounts Receivable | $4.6M | 8.2% |
| Inventory | $16.8M | 30.1% |
| Property, Plant & Equipment | $4.6M | 8.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $12.7M | 22.8% |
Liabilities Breakdown
Total Liabilities: $66.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.3M | 18.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $54.2M | 81.5% |